Mater Research Institute, University of Queensland, South Brisbane, Queensland, Australia.
BMJ Open. 2019 Jun 17;9(6):e027100. doi: 10.1136/bmjopen-2018-027100.
Severe maternal morbidity (SMM) includes conditions that are on a continuum of maternal morbidity to maternal death. Rates of SMM are increasing both in high-income countries (HICs) as well as in low/middle-income countries (LMICs). There is evidence that analysis of SMM trends and detailed investigation of factors implicated in these cases may reflect the standard of maternal healthcare both in HICs and LMICs. SMM is also associated with poorer perinatal outcomes. The aim of this protocol is to describe the proposed methodology for the synthesis and analyses of the data describing the relationship between SMM and adverse perinatal outcomes in a systematic review and meta-analysis.
This systematic review and meta-analysis will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and will be registered with the International Prospective Register of Systematic Reviews (PROSPERO). Original peer-reviewed epidemiologic/clinical studies of observational (cross-sectional, cohort, case-control) and randomised controlled trial studies conducted in high-income countries will be included. An electronic search of PubMed, Embase, CINAHL and Scopus databases will be performed without restricting publication date/year. Two authors will independently screen the titles, review abstracts and perform data extraction. Where possible, meta-analyses will be done to calculate pooled estimates.
As this is a protocol for systematic review and meta-analysis of published data, ethics review and approval are not required. The findings will be published in peer-reviewed journals and disseminated at scientific conferences.
CRD42019130933.
严重孕产妇发病率(SMM)包括从孕产妇发病率到孕产妇死亡的一系列疾病。高收入国家(HICs)和中低收入国家(LMICs)的 SMM 发生率都在上升。有证据表明,分析 SMM 趋势并详细调查这些病例中涉及的因素,可能反映了 HIC 和 LMIC 中孕产妇保健的标准。SMM 也与围产儿结局较差有关。本方案旨在描述一项系统评价和荟萃分析的拟议方法,用于综合分析描述 SMM 与不良围产儿结局之间关系的数据。
本系统评价和荟萃分析将遵循系统评价和荟萃分析的首选报告项目(PRISMA)指南,并在国际前瞻性系统评价注册库(PROSPERO)中进行注册。将纳入在高收入国家进行的观察性(横断面、队列、病例对照)和随机对照试验研究的原始同行评审的流行病学/临床研究。将对 PubMed、Embase、CINAHL 和 Scopus 数据库进行电子检索,不限制出版日期/年份。两位作者将独立筛选标题、审查摘要并进行数据提取。在可能的情况下,将进行荟萃分析以计算汇总估计值。
由于这是对已发表数据进行系统评价和荟萃分析的方案,因此不需要伦理审查和批准。研究结果将发表在同行评议的期刊上,并在科学会议上传播。
PROSPERO 注册号:CRD42019130933。